Clinical Trial Update: Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing efficacy and safety of gemcabene in patients with low HDL-C and varying triglyceride levels; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hypertriglyceridemia

Drugs mentioned

• gemcabene (gemcabene)

Snippet

Sponsor: NeuroBo Pharmaceuticals Inc. | Conditions: Hypercholesterolemia, Hypertriglyceridemia | Phase 2 | Status: COMPLETED